1,3-Butadiene is a multisite carcinogen in rodents. Incidences of cardiac hemangiosarcomas were significantly increased in male and female B6C3F1 mice that inhaled 1,3-butadiene (BD) for 2 years. Eleven BD-induced cardiac hemangiosarcomas were examined for genetic alterations in ras protooncogenes and in the p53 tumor suppressor gene. Nine of 11 (82%) BD-induced hemangiosarcomas had K-ras mutations and 5 of 11 (46%) had H-ras mutations. All of the K-ras mutations were G&rarr;C transversions (GGC&rarr;CGC) at codon 13; this pattern is consistent with reported results in BD-induced lung neoplasms and lymphomas. Both K-ras codon 13 CGC mutations and H-ras codon 61 CGA mutations were detected in 5 of 9 (56%) hemangiosarcomas. The 11 hemangiosarcomas stained positive for p53 protein by immunohistochemistry and were analyzed for p53 mutations using cycle sequencing of polymerase chain reaction (PCR) amplified DNA isolated from paraffin-embedded sections. Mutations in exons 5 to 8 of the p53 gene were identified in 5 of 11 (46%) hemangiosarcomas, and all of these were from the 200-or 625-ppm exposure groups that also had K-ras codon 13 CGC mutations. Our data indicate that K-ras , H-ras , and p53 mutations in these hemangiosarcomas most likely occurred as a result of the genotoxic effects of BD and that these mutations may play a role in the pathogenesis of BD-induced cardiac hemangiosarcomas in the B6C3F1 mouse.
INTRODUCTION '
Hemangiosarcomas are malignant neoplasms of endothelial cell origin and are generally highly aggressive and lethal. In humans the heart, liver, skeletal muscle, and skin are the most common sites of hemangiosarcomas.
Exposure to a number of chemicals, including vinyl chloride, arsenic, and Thorotrast, have been associated with hemangiosarcoma development, primarily of the liver (1, 7, 37, 48) . Similarly, in B6C3F1 mice increased incidences of hemangiosarcomas have been reported following chronic exposure to environmental chemicals such as p-chloroaniline hydrochloride, pentachloroanisol, pentachlorophenol dowicide EC7, 1,2-propylene oxide, tetrafluoroethylene, chloroprene, and 1,3 butadiene (24, 35) . Chemically induced hemangiosarcomas in mice are often multicentric in origin. The hemangiosarcomas in the 1,3-butadiene study were of interest because of the unusual site specificity for these tumors in the cardiovascular system, specifically the heart (25, 33) .
1,3-Butadiene is used mainly in the manufacture of synthetic rubber and thermoplastic resins (33) . Approximately 6 million tons per year are produced worldwide.
1,3-Butadiene is metabolized to mutagenic and carcinogenic epoxides in all mammalian species tested (8, 31, 41) . The major genotoxic metabolites identified to date are epoxybutene and diepoxybutane (6, 30) . Various DNA adducts have been reported following in vitro or in vivo exposure to either butadiene or its genotoxic metabolites (5, 6, 27, 42) . Following inhalation exposure, 1,3-butadiene has been shown to induce in vivo point mutations at both A:T and G:C base pairs (14, 47, 49, 55) .
Genetic alterations in oncogenes and tumor suppressor genes in rodent and human tumors may provide important insights regarding the molecular pathogenesis of chemical carcinogenesis (16, 26, 39, 44) . In some tumors characteristic types of DNA base pair changes in ras oncogenes and the p53 tumor suppressor gene may be linked to the mutagenic specificities or DNA adduct formation of environmental agents (9, 11, 19, 22, 46) . For example, in liver hemangiosarcomas from vinyl chlorideexposed factory workers, the N6-ethenoadduct has been postulated to lead to specific A~T transversions in the p53 tumor suppressor gene (19, 32 tissue from 3 BD-exposed mice was analyzed since there were no spontaneous hemangiosarcomas in the air controls from this study.
DNA Isolation. The DNA isolation procedure was described previously (45 
RESULTS
The cardiac hemangiosarcomas occurred in all ventricular locations (Figure la) and occasionally invaded through the epicardium (Figure lb) . The 11 hemangiosarcomas examined were positive for the p53 protein by immunohistochemistry (Figure 1 c, d ). In order to obtain a representative characterization of p53 protein staining in other hemangiosarcomas in this study, we randomly selected 10 hemangiosarcomas that were smaller than 1 mm in diameter; 7 of 10 of these hemangiosarcomas were positive for the p53 protein (data not shown).
Nine of 11 (82%) BD-induced hemangiosarcomas had K-ras mutations, and all 9 had G---3C transversions (GGC~CGC) at codon 13 (Table 1 and Figure 2) . Five of the 9 hemangiosarcomas with K-ras codon 13 mutation also had an H-ras codon 61 CGA mutation ( K-ras, or H-ras were detected in 2 of 11 BD-induced hemangiosarcomas or in DNA isolated from any nontumor regions of the heart in 3 BD-exposed mice. The lack of p53 mutations in tumor samples that were positive by immunohistochemical methods for the p53 protein may be due to mutations outside the exons 5 to 8 evaluated (4) or to changes in the expression of other genes that influence the expression of p53 (36) . All of the mutations were reproducible through duplicate experiments including PCR, SSCP, and sequencing analysis, which ensured the specificity of the results.
DISCUSSION
The K-ras and H-ras mutation spectra identified in these cardiac hemangiosarcomas are characteristic of direct DNA damage as detected previously in other neoplasms from mice exposed to 1,3-butadiene. For example, a high frequency of K-ras codon 13 G-3C transversions has been identified in lung neoplasms and lymphomas of mice exposed to 1,3-butadiene (14, 55) . In addition, a high number of H-ras A~G transitions has been detected in 1,3-butadiene-induced Harderian gland neoplasms (15) . Both K-ras codon 13 G-C transversions and Hras codon 61 A-G transitions have been detected only rarely in spontaneous neoplasms of the B6C3F1 mouse (44) . The targeting of guanine and adenine bases is consistent with the formation of N-guanine and N-adenine adducts following metabolism of 1,3-butadiene by the cytochrome P450 monooxygenase system.
In this study we found a moderately high frequency of p53 mutations in the cardiac hemangiosarcomas. A majority of the mutations were GC-AT transitions or GC~CG transversions, consistent with butadiene adduct formation. Similar spectra of p53 mutations have been identified in mammary and lymphoid neoplasms following 1,3-butadiene exposure in mice (53, 55, 56) . Further evidence that mutation of p53 may be involved in 1,3-butadiene-induced hemangiosarcoma formation is provided by tumorigenesis findings in p53 knockout mice. Hemangiosarcomas have been found in 6 of 56 ( 11 %) untreated p53 heterozygous (+/-) mice and in 10 of 60 (18%) untreated p53 homozygous (-/-) knockout mice. Multiple hemangiosarcomas of the liver were found in 14 of 17 (82%) p53 heterozygous mice when low dose levels of dimethylnitrosamine (0.0005%) were added to the drinking water (17) . Collectively, the p53 mutation data from our study and studies with p53 knockout mice suggest that genetic alterations in the p53 gene contribute to induction of hemangiosarcomas.
The finding of multiple mutations in 1,3-butadiene-induced hemangiosarcomas is consistent with the theory of a multistage process of carcinogenesis (29) 
